Stéphane Minvielle

11.5k citations

146 papers · 4.5k indexed · h-index 34

Impact in

Hematology top 0.2%
- Multiple Myeloma Research and Treatments
Oncology top 2%
- Peptidase Inhibition and Analysis
- Cytokine Signaling Pathways and Interactions

Papers in

Hematology 85
- Multiple Myeloma Research and Treatments 85
Cancer Research 26
- Cancer Genomics and Diagnostics 9

Co-authors: Hervé Avet‐Loiseau Florence Magrangeas Régis Bataille Jean‐Luc Harousseau Philippe Moreau Thierry Façon Nikhil C. Munshi Michel Attal
Journals: Blood (59 papers)Journal of Clinical Oncology (9 papers)Leukemia (7 papers)Journal of Biological Chemistry (4 papers)FEBS Letters (4 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Stéphane Minvielle

137 papers receiving 4.4k citations

Peers

Countries citing papers authored by Stéphane Minvielle

Since Specialization

Citations

This map shows the geographic impact of Stéphane Minvielle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Minvielle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Minvielle more than expected).

Fields of papers citing papers by Stéphane Minvielle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Minvielle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Minvielle. The network helps show where Stéphane Minvielle may publish in the future.

Co-authors

The 25 scholars most cited alongside Stéphane Minvielle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stéphane Minvielle Line = papers co-authored together Stéphane Minvielle links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mechanisms of resistance to bispecific T-cell engagers in multiple myeloma and their clinical implications Blood Advances ·Éric Letouzé, Philippe Moreau, Nikhil Munshi, Mehmet Samur, Stéphane Minvielle, Cyrille Touzeau	2024	18
2	CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma Blood ·Salomé Decombis, Céline Bellanger, Yannick Le Bris, Candice Madiot, Jane Jardine, Juliana C. Santos, Delphine Boulet, Christelle Dousset, Audrey Ménard, Charlotte Kervoëlen, Elise Douillard, Philippe Moreau, Stéphane Minvielle, Agnès Moreau‐Aubry, Benoît Tessoulin, Gaël Roué, Nicolas Bidère, Steven Le Gouill, Catherine Pellat‐Deceunynck, David Chiron	2023	11
3	A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics Blood ·Romane Durand, Géraldine Descamps, Céline Bellanger, Christelle Dousset, Sophie Maïga, Jean-Baptiste Alberge, Jennifer Derrien, Jonathan Cruard, Stéphane Minvielle, Nicoletta Libera Lilli, Catherine Godon, Yannick Le Bris, Benoît Tessoulin, Martine Amiot, Patricia Gomez‐Bougie, Cyrille Touzeau, Philippe Moreau, David Chiron, Agnès Moreau‐Aubry, Catherine Pellat‐Deceunynck	2023	7
4	Exploring the impact of dexamethasone on gene regulation in myeloma cells Life Science Alliance ·Victor Bessonneau-Gaborit, Jonathan Cruard, Catherine Guérin‐Charbonnel, Jennifer Derrien, Jean-Baptiste Alberge, Elise Douillard, Magali Devic, Sophie Deshayes, L. Campion, Frank Westermann, Philippe Moreau, Carl Herrmann, Jérémie Bourdon, Florence Magrangeas, Stéphane Minvielle	2023	3
5	High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma Blood ·Mehmet Samur, Marco Roncador, Anıl Aktaş Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphaël Szalat, Masood A. Shammas, Adam S. Sperling, Paul G. Richardson, Florence Magrangeas, Stéphane Minvielle, Aurore Perrot, Jill Corre, Philippe Moreau, Anjan Thakurta, Giovanni Parmigiani, Kenneth C. Anderson, Hervé Avet‐Loiseau, Nikhil C. Munshi	2023	22
6	Molecular Signature of ¹⁸F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study Journal of Nuclear Medicine ·Jean-Baptiste Alberge, Françoise Kraeber‐Bodéré, Bastien Jamet, Cyrille Touzeau, Hélène Caillon, Soraya Wuillème, Marie C. Béné, Tobias Kampfenkel, Pieter Sonneveld, Mark van Duin, Hervé Avet‐Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet‐Milin, Michel Chérel, Philippe Moreau, Stéphane Minvielle, Clément Bailly	2022	10
7	The glycoprotein GP130 governs the surface presentation of the G protein–coupled receptor APLNR The Journal of Cell Biology ·Kilian Trillet, Kathryn Jacobs, Gwennan André‐Grégoire, An Thys, Clément Maghe, Jonathan Cruard, Stéphane Minvielle, Sara Gonzalez Diest, Guillaume Montagnac, Nicolas Bidère, Julie Gavard	2021	3
8	The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma Leukemia ·Sophia Adamia, Ivane Abiatari, Samirkumar B. Amin, Mariateresa Fulciniti, Stéphane Minvielle, Li Cheng, Philippe Moreau, Hervé Avet‐Loiseau, Nikhil C. Munshi, Kenneth C. Anderson	2019	9
9	Expressed fusion gene landscape and its impact in multiple myeloma Nature Communications ·Alice Cleynen, Raphaël Szalat, Mehmet Samur, Sébastien Robiou du Pont, Laure Buisson, E. Boyle, Marie‐Lorraine Chrétien, Kenneth C. Anderson, Stéphane Minvielle, Philippe Moreau, Michel Attal, Giovanni Parmigiani, Jill Corre, Nikhil C. Munshi, Hervé Avet‐Loiseau	2017	25
10	A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma Clinical Cancer Research ·Florence Magrangeas, Rowan Kuiper, Hervé Avet‐Loiseau, Wilfried Gouraud, Catherine Guérin‐Charbonnel, Ludovic Ferrer, Alexandre Aussem, Haytham Elghazel, Jérôme Suhard, Henri Der Sakissian, Michel Attal, Nikhil C. Munshi, Pieter Sonneveld, Charles Dumontet, Philippe Moreau, Mark van Duin, L. Campion, Stéphane Minvielle	2016	30
11	Significant Biological Role of Sp1 Transactivation in Multiple Myeloma Clinical Cancer Research ·Mariateresa Fulciniti, Samirkumar B. Amin, Puru Nanjappa, Scott J. Rodig, Rao Prabhala, Cheng Li, Stéphane Minvielle, Yu-Tzu Tai, Pierfrancesco Tassone, Hervé Avet‐Loiseau, Teru Hideshima, Kenneth C. Anderson, Nikhil C. Munshi	2011	42
12	Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor? Blood ·Hervé Avet‐Loiseau, Florent Malard, L. Campion, Florence Magrangeas, Catherine Sebban, Bruno Lioure, Olivier Decaux, Thierry Lamy, Laurence Legros, Jean‐Gabriel Fuzibet, Mauricette Michallet, Bernadette Corront, Pascal Lenain, Cyrille Hulin, Claire Mathiot, Michel Attal, Thierry Façon, Jean‐Luc Harousseau, Stéphane Minvielle, Philippe Moreau, (unknown)	2010	92
13	Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p) Journal of Clinical Oncology ·Hervé Avet‐Loiseau, Xavier Leleu, Murielle Roussel, Philippe Moreau, Catherine Guérin‐Charbonnel, Denis Caillot, Gérald Marit, Lotfi Benboubker, Laurent Voillat, Claire Mathiot, Brigitte Kolb, Margaret Macro, L. Campion, Marc Wetterwald, Anne‐Marie Stoppa, Cyrille Hulin, Thierry Façon, Michel Attal, Stéphane Minvielle, Jean‐Luc Harousseau	2010	298
14	Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome Journal of Clinical Oncology ·Olivier Decaux, Laurence Lodé, Florence Magrangeas, Catherine Guérin‐Charbonnel, Wilfried Gouraud, Pascal Jézéquel, Michel Attal, Jean‐Luc Harousseau, Philippe Moreau, Régis Bataille, L. Campion, Hervé Avet‐Loiseau, Stéphane Minvielle	2008	269
15	Negative regulation of oncostatin M (OM) signalling by suppressor of cytokine signalling-3 (SOCS-3). European Cytokine Network ·Florence Magrangeas, Olivier Boisteau, Sébastien DENIS, Y. Jacques, Stéphane Minvielle	2001	5
16	Monoclonal antibodies against the human interleukin-11 receptor alpha-chain (IL-11Rα) and their use in studies of human mononuclear cells Journal of Immunological Methods ·Chrystel Blanc, Patricia Vusio, Karin Schleinkofer, Olivier Boisteau, Stefan Pflanz, Stéphane Minvielle, Joachim Grötzinger, Gerhard Müller‐Newen, Peter C. Heinrich, Yannick Jacques, Félix A. Montero‐Julian	2000	10
17	14q32 chromosomal translocations: a hallmark of plasma cell dyscrasias? The Hematology Journal ·Hervé Avet‐Loiseau, Stéphane Minvielle, Marie‐Paule Mellerin, Florence Magrangeas, Régis Bataille	2000	6
18	Natural Splicing of Exon 2 of Human Interleukin-15 Receptor α-Chain mRNA Results in a Shortened Form with a Distinct Pattern of Expression Journal of Biological Chemistry ·Sigrid Dubois, Florence Magrangeas, Philippe Lehours, Sylvie Raher, Jérôme Bernard, Olivier Boisteau, Sabine Léroy, Stéphane Minvielle, Anne Godard, Yannick Jacques	1999	74
19	Reconstitution of two isoforms of the human interleukin‐11 receptor and comparison of their functional properties FEBS Letters ·B. Lebeau, Felix A Montero Julian, John Wijdenes, Gerhard Müller‐Newen, Heike Dahmen, Michel Chérel, Peter C. Heinrich, Hervé Brailly, Marie‐Martine Hallet, Anne Godard, Stéphane Minvielle, Yannick Jacques	1997	29
20	The Human Interleukin-11 Receptor α Gene (IL11RA): Genomic Organization and Chromosome Mapping Genomics ·Michel Chérel, M. Sorel, Françoise Apiou, B. Lebeau, Sigrid Dubois, Yannick Jacques, Stéphane Minvielle	1996	7

About Stéphane Minvielle

Stéphane Minvielle is a scholar working on Hematology, Cancer Research, Oncology, History and Philosophy of Science and Molecular Biology, having authored 146 papers that have together received 4.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (85 papers), Protein Degradation and Inhibitors (34 papers), Peptidase Inhibition and Analysis (22 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Glycosylation and Glycoproteins Research (11 papers), Cytokine Signaling Pathways and Interactions (10 papers), Cancer Genomics and Diagnostics (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Hematology (2.7k citations), Oncology (1.6k citations), Molecular Biology (3.2k citations), Genetics (454 citations) and Cancer Research (575 citations). Stéphane Minvielle has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Hervé Avet‐Loiseau, Florence Magrangeas, Régis Bataille, Jean‐Luc Harousseau, Philippe Moreau, Thierry Façon, Nikhil C. Munshi, Michel Attal, L. Campion and Catherine Guérin‐Charbonnel. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Journal of Biological Chemistry and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact